Subscribe Become an Author Sign Up Log In

Network Driven Drug Discovery Using AI

   by Andrii Buvailo    3053    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

“One-target-one-disease” paradigm has been around for decades, prompting numerous drug discovery programs focusing on identifying small molecules for targeting only one specific protein (or other targets) believed to be responsible for the disease mechanism.

However, the limitations of such approach and the inability of “one-target-one-disease” way of thinking to comprehend the complexity of biological processes led an increasing interest in polypharmacology programs, multi-omics, and network biology.

One such company that is using network driven drug discovery approach is e-Therapeutics. Watch their recent video with an illustrative explanation of how understanding a bigger picture of cells and disease mechanisms can be a much more efficient way of creating better drugs. Since network driven drug discovery approach is a data-driven approach, the company uses artificial intelligence (AI) to efficiently deal with complex datasets.

Share this:              

You may also be interested to read:

 

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *